1. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Issue 10274 (13th February 2021) Authors: Abaleke, Eugenia; Abbas, Mustafa; Abbasi, Sadia; Abbott, Alfie; Abdelaziz, Ashraf; Abdelbadiee, Sherif; Abdelfattah, Mohamed; Abdul, Basir; Abdul Rasheed, Althaf; Abdul-Kadir, Rezan; Abdulmumeen, Abdulfatahi; Abdulshukkoor, Niyaz; Abdusamad, Kula; Abed El Khaleq, Yazeed; Abedalla, Mai; Abeer Ul A... Journal: Lancet Issue: Volume 397:Issue 10274(2021) Page Start: 605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GENOMIC PROFILING OF PRIMARY AND MATCHED RECURRENT GLIOBLASTOMA TUMOURS REVEALS THAT THE MUTATIONAL LANDSCAPE INCLUDES CLINICALLY ACTIONABLE VARIATION. (3rd October 2018) Authors: McInerney, Caitríona; Ellis, Hayley; Schrinpf, Daniel; Sahm, Felix; Stupnikov, Alexei; Wadsley, Marc; Wragg, Christopher; White, Paul; McArt, Darragh; Kurian, Kathreena Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 5 Page Start: v351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mutational landscape of primary and recurrent glioblastoma reveals potentially actionable SNVs including WNT pathway variation. (31st January 2018) Authors: Ellis, Hayley; Sahm, Felix; Schrimpf, Daniel; Stupnikov, Alexei; Wadsley, Mark; Wragg, Christopher; McArt, Darragh; Kurian, Kathreena Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 1 Page Start: i16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗